PDPatricia M. Dietz

Patricia M. Dietz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Patricia M. Dietz has a total of 48 co-authors. Here are the top co-authors by number of shared publications:

  • William M. Callaghan

    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, USA

    4 shared publications
  • Brian Morrow

    From the National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Ga

    2 shared publications
  • Lucinda J. England

    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, USA

    2 shared publications
  • Mary E. Cogswell

    From the National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Ga

    2 shared publications
  • Abigail Viall

    Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

    1 shared publication
  • Agustina Mazzoni

    Instituto de Efectividad Clínica y Sanitaria (IECS), Buenos Aires, Argentina

    1 shared publication

Latest Publications

  • Top Cited Papers

    National and State Estimates of Adults with Autism Spectrum Disorder

    by Patricia M. Dietz, Charles E. Rose, Dedria McArthur, Matthew Maenner

    U.S. national and state population-based estimates of adults living with autism spectrum disorder (ASD) are nonexistent due to the lack of existing surveillance systems funded to address this need. Therefore, we estimated national and state prevalence of adults 18–84 years living with ASD using simulation in conjunction with Bayesian hierarchal models. In 2017, we estimated that approximately 2.21% (95% simulation interval (SI) 1.95%, 2.45%) or 5,437,988 U.S. adults aged 18 and older have ASD, with state prevalence ranging from 1.97% (95% SI 1.55%, 2.45%) in Louisiana to 2.42% (95% SI 1.93%, 2.99%) in Massachusetts. Prevalence and case estimates of adults living with ASD (diagnosed and undiagnosed) can help states estimate the need for diagnosing and providing services to those unidentified.


  • Open Access

    HIV Testing among Outpatients with Medicaid and Commercial Insurance

    by Patricia M. Dietz, Michelle Van Handel, Huisheng Wang, Philip J. Peters, Jun Zhang, Abigail Viall, Bernard M. Branson

    To assess HIV testing and factors associated with receipt of testing among persons with Medicaid and commercial insurance during 2012. Outpatient and laboratory claims were analyzed from two databases: all Medicaid claims from six states and all claims from Medicaid health plans from four other states and a large national convenience sample of patients with commercial insurance in the United States. We excluded those aged 64 years, enrolled <9 of the 12 months, pregnant females, and previously diagnosed with HIV. We identified patients with new HIV diagnoses that followed (did not precede) the HIV test, using HIV ICD-9 codes. HIV testing percentages were assessed by patient demographics and other tests or diagnoses that occurred during the same visit. During 2012, 89,242 of 2,069,536 patients (4.3%) with Medicaid had at least one HIV test, and 850 (1.0%) of those tested received a new HIV diagnosis. Among 27,206,804 patients with commercial insurance, 757,646 (2.8%) had at least one HIV test, and 5,884 (0.8%) of those tested received a new HIV diagnosis. During visits that included an HIV test, 80.2% of Medicaid and 83.0% of commercial insurance claims also included a test or diagnosis for a sexually transmitted infection (STI), and/or Hepatitis B or C virus at the same visit. HIV testing primarily took place concurrently with screening or diagnoses for STIs or Hepatitis B or C. We found little evidence to suggest routine screening for HIV infection was widespread.


  • Open Access

    Epidemiology and Risk Factors for Ebola Virus Disease in Sierra Leone—23 May 2014 to 31 January 2015

    by Patricia M. Dietz, Amara Jambai, Janusz T. Paweska, Zabulon Yoti, Thomas G. Ksaizek

    Background. Sierra Leone has the most cases of Ebola virus disease (EVD) ever reported. Trends in laboratory-confirmed EVD, symptom presentation, and risk factors have not been fully described. Methods. EVD cases occurring from 23 May 2014 to 31 January 2015 are presented by geography, demographics, and risk factors for all persons who had laboratory-confirmed EVD, which was identified by Ebola virus–specific reverse-transcription polymerase chain reaction–based testing. Results. During the study period, 8056 persons had laboratory-confirmed EVD. Their median age was 28 years; 51.7% were female. Common symptoms included fever (90.4%), fatigue (88.3%), loss of appetite (87.0%), headache (77.9%), joint pain (73.7%), vomiting (71.2%), and diarrhea (70.6%). Among persons with confirmed cases, 47.9% reported having had contact with someone with suspected EVD or any sick person, and 25.5% reported having attended a funeral, of whom 66.2% reported touching the body. The incidence of EVD was highest during 1–30 November 2014, at 7.5 per 100 000 population per week, and decreased to 2.1 per week during 1–31 January 2015. Between 23 May and 30 August 2014, two districts had the highest incidence of 3.8 and 7.0 per 100 000 population per week which decreased >97% by 1–31 January 2015. In comparison, the districts that include the capital city reported a 10-fold increase in incidence per week during the same time periods. Conclusions. Almost half of patients with EVD in Sierra Leone reported physical contact with a person ill with EVD or a dead body, highlighting prevention opportunities.


  • Open Access

    Tobacco cessation intervention for pregnant women in Argentina and Uruguay: study protocol

    by Fernando Althabe, Alicia Alemán, Agustina Mazzoni, Mabel Berrueta, Paola Morello, Mercedes Colomar, Alvaro Ciganda, Ana Becú, Luz Gibbons, Laura Llambi, et al.

    Background: Argentina and Uruguay are among the countries with the highest proportion of pregnant women who smoke. The implementation of an effective smoking cessation intervention would have a significant impact on the health of mothers and infants. The “5 A’s” (Ask, Advise, Assess, Assist, Arrange) is a strategy consisting of a brief cessation counseling session of 5–15 minutes delivered by a trained provider. The “5 A’s” is considered the standard of care worldwide; however, it is under used in Argentina and Uruguay.Methods: We will conduct a two-arm, parallel cluster randomized controlled trial of an implementation intervention in 20 prenatal care settings in Argentina and Uruguay. Prenatal care settings will be randomly allocated to either an intervention or a control group after a baseline data collection period. Midwives’ facilitators in the 10 intervention prenatal clinics (clusters) will be identified and trained to deliver the “5 A’s” to pregnant women and will then disseminate and implement the program. The 10 clusters in the control group will continue with their standard in-service activities. The intervention will be tailored by formative research to be readily applicable to local prenatal care services at maternity hospitals and acceptable to local pregnant women and health providers. Our primary hypothesis is that the intervention is feasible in prenatal clinics in Argentina and Uruguay and will increase the frequency of women receiving tobacco use cessation counseling during pregnancy in the intervention clinics compared to the control clinics. Our secondary hypotheses are that the intervention will decrease the frequency of women who smoke by the end of pregnancy, and that the intervention will increase the attitudes and readiness of midwives towards providing counseling to women in the intervention clinics compared to the control clinics.Trial registration: ClinicalTrials.gov. Identifier:NCT01852617


  • Health Care Utilization in the First Year of Life among Small- and Large- for-Gestational Age Term Infants

    by Patricia M. Dietz, Joanne H. Rizzo, Lucinda J. England, William M. Callaghan, Kimberly K. Vesco, F. Carol Bruce, Joanna E. Bulkley, Andrea J. Sharma, Mark C. Hornbrook

    The objective of the study was to assess if small- and large-for gestational age term infants have greater health care utilization during the first year of life. The sample included 28,215 singleton term infants (37–42 weeks) without major birth defects delivered from 1998 through 2007 and continuously enrolled at Kaiser Permanente Northwest for 12 months after delivery. Birth weight for gestational age was categorized into 3 levels: 90th percentile (LGA). Length of delivery hospitalization, re-hospitalizations and sick/emergency room visits were obtained from electronic records. Logistic regression models estimated associations between birth weight category and re-hospitalization. Generalized linear models estimated adjusted mean number of sick/emergency visits. Among term infants, 6.2 % were SGA and 13.9 % were LGA. Of infants born by cesarean section, SGA infants had 2.7 higher odds [95 % 1.9, 3.8] than AGA infants of staying ≥5 nights during the delivery hospitalization; of those born vaginally, SGA infants had 1.5 higher adjusted odds [95 % 1.1, 2.1] of staying ≥4 nights. LGA compared to AGA infants had higher odds of re-hospitalization within 2 weeks of delivery [OR 1.25, 95 % CI 0.99, 1.58] and of a length of stay ≥4 days during that hospitalization [OR 2.6, 95 % CI 1.3, 5.0]. The adjusted mean number of sick/emergency room visits was slightly higher in SGA (7.8) than AGA (7.5) infants (P < .05). Term infants born SGA or LGA had greater health care utilization than their counterparts, although the increase in utilization beyond the initial delivery hospitalization was small.


  • A comparison of LMP‐based and ultrasound‐based estimates of gestational age using linked California livebirth and prenatal screening records

    by Patricia M. Dietz, Lucinda J. England, William M. Callaghan, Michelle Pearl, Megan L. Wier, Martin Kharrazi

    Summary: Although early ultrasound (<20 weeks' gestation) systematically underestimates the gestational age of smaller fetuses by approximately 1–2 days, this bias is relatively small compared with the large error introduced by last menstrual period (LMP) estimates of gestation, as evidenced by the number of implausible birthweight‐for‐gestational age. To characterise this misclassification, we compared gestational age estimates based on LMP from California birth certificates with those based on early ultrasound from a California linked Statewide Expanded Alpha‐fetoprotein Screening Program (XAFP). The final sample comprised 165 908 women. Birthweight distributions were plotted by gestational age; sensitivity and positive predictive value for preterm rates according to LMP were calculated using ultrasound as the ‘gold standard’.For gestational ages 20–27 and 28–31 weeks, the LMP‐based birthweight distributions were bimodal, whereas the ultrasound‐based distributions were unimodal, but had long right tails. At 32–36 weeks, the LMP distribution was wider, flatter, and shifted to the right, compared with the ultrasound distribution. LMP vs. ultrasound estimates were, respectively, 8.7% vs. 7.9% preterm (14 days. The groups most likely to have inconsistent gestational age estimates included African American and Hispanic women, younger and less‐educated women, and those who entered prenatal care after the second month of pregnancy. In conclusion, we found substantial misclassification of LMP‐based gestational age.The 2003 revised US Standard Certificate of Live Birth includes a new gestational age item, the obstetric estimate. It will be important to assess whether this estimate addresses the problems presented by LMP‐based gestational age.


  • Combined Effects of Prepregnancy Body Mass Index and Weight Gain During Pregnancy on the Risk of Preterm Delivery

    by Patricia M. Dietz, William M. Callaghan, Mary E. Cogswell, Brian Morrow, Cynthia Ferre, Laura A. Schieve

    Background: The association between excessive gestational weight gain and preterm delivery is unclear, as is the association between low gestational weight gain and preterm delivery among overweight and obese women. Methods: Using data from the Pregnancy Risk Assessment Monitoring System in 21 states, we estimated the risk of very (20–31 weeks) and moderately (32–36 weeks) preterm delivery associated with a combination of prepregnancy body mass index (BMI) and gestational weight gain among 113,019 women who delivered a singleton infant during 1996–2001. We categorized average weight gain (kilograms per week) as very low (0.79). We categorized prepregnancy BMI (kg/m2) as underweight (<19.8), normal (19.8–26.0), overweight (26.1–28.9), obese (29.0–34.9), or very obese (≥35.0). We examined associations for all women and for all women with no complications adjusting for covariates. Results: There was a strong association between very low weight gain and very preterm delivery that varied by prepregnancy BMI, with the strongest association among underweight women (adjusted odds ratio = 9.8; 95% confidence interval = 7.0–13.8) and the weakest among very obese women (2.3; 1.8–3.1). Very low weight gain was not associated with moderately preterm delivery for overweight or obese women. Women with very high weight gain had approximately twice the odds of very preterm delivery, regardless of prepregnancy BMI. Conclusions: This study supports concerns about very low weight gain during pregnancy, even among overweight and obese women, and also suggests that high weight gain, regardless of prepregnancy BMI, deserves further investigation.


  • Population-Based Assessment of the Risk of Primary Cesarean Delivery Due to Excess Prepregnancy Weight Among Nulliparous Women Delivering Term Infants

    by Patricia M. Dietz, William M. Callaghan, Brian Morrow, Mary E. Cogswell

    Objective: To estimate the risk of cesarean delivery due to excess prepregnancy body mass index (BMI) in a multistate, US population-based sample. Methods: We analyzed data from the population-based Pregnancy Risk Assessment Monitoring System (PRAMS) on 24,423 nulliparous women with single, term infants delivered between 1998 and 2000 in 19 states. We calculated BMI from self-reported weight and height. We assessed interactions between prepregnancy BMI and other risk factors. We estimated weighted relative risks and 95% confidence intervals for the association between prepregnancy BMI and cesarean section from multiple logistic regression models adjusting for demographic and medical risk factors from the PRAMS questionnaire or birth certificates. Results: The incidence of cesarean delivery increased with increased prepregnancy BMI, from 14.3% (0.8 standard error (SE)) for lean women (BMI < 19.8) to 42.6% (2.0 SE) for very obese women (BMI ≥ 35). The risk of cesarean section differed by presence of any medical, labor and/or delivery complication. Among women with any complication, the estimated adjusted RR for cesarean delivery was 1.1 (95% confidence interval (CI) 1.0–1.2) among overweight women, 1.3 (95% CI 1.1–1.4) among obese women, and 1.4 (95% CI 1.2–1.6) among very obese women compared with normal weight women. Among women without any complications, the estimated adjusted RR was 1.4 (95% CI 1.0–1.8) among overweight women, 1.5 (95% CI 1.1–2.1) among obese women, and 3.1 (95% CI 2.3–4.8) among very obese women. Conclusion: Excess prepregnancy weight increases the risk of cesarean delivery among nulliparous women giving birth to single, term infants, especially among very obese women without any complications.


  • Prenatal Smoking in Two Consecutive Pregnancies: Georgia, 1989–1992

    by Patricia M. Dietz, Melissa M. Adams, Roger W. Rochat, Mary P. Mathis

    Objective: To explore the patterns of prenatal smoking among women whose first and second pregnancies ended in live births. Methods:We used population-based data to explore prenatal smoking among...